Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Wegovy (semaglutide) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and supports weight management when combined with lifestyle changes
Meta-analysis findings: GLP-1 receptor agonist medications average 12.5% weight loss versus lipase inhibitors at 6.2%, confirming Wegovy as the more effective weight loss treatment for most patients seeking significant weight loss
May 14, 2025
It is non-surgical and well-tolerated
Option 2: Up to 12.5 mg of compounded semaglutide every 90 days with injection kit (includes needles, syringes & alcohol swabs)
US$ 26.32
US$ 21.60
US$ 24.70
US$ 28.79
US$ 28.97
US$ 22.36
US$ 22.25
US$ 23.78
US$ 28.15
US$ 21.92
